111 related articles for article (PubMed ID: 38858110)
1. [Effect of endoscopic surgery combined with chemotherapy and radiotherapy on prognosis of early nasopharyngeal carcinoma patients in high incidence area].
Weng J; Gao J; Li M; Wei J; Zhang S; Lan G; Li B; Qin D; Huang B; Zhu Z; Su X; Peng Y; Qu S; Qiu Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Jun; 38(6):472-476;484. PubMed ID: 38858110
[No Abstract] [Full Text] [Related]
2. [Observation on clinical efficacy and prognosis analysis of endoscopic surgery treatment for rT1-rT2 recurrent nasopharyngeal carcinoma].
Lan GP; Weng JJ; Si YF; Deng ZX; Huang B; Zhang BJ; Qin Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 33(4):337-341. PubMed ID: 30970405
[No Abstract] [Full Text] [Related]
3. Influence of endoscopic sinus surgery on the quality of life of patients with early nasopharyngeal carcinoma and the analysis of prognosis-related factors.
Si YF; Lan GP; Deng ZX; Weng JJ; Si JY; Qin YD; Huang B; Wang YL; Yang Y; Qin Y; Zhang BJ; Han X; Xiong WM
Tumour Biol; 2017 Jul; 39(7):1010428317707435. PubMed ID: 28714364
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
[TBL] [Abstract][Full Text] [Related]
5. [Clinical assessment of the radiotherapy and chemotherapy combined with cetuximabin in the treatment of nasopharyngeal carcinoma].
Wang XX
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Aug; 30(15):1229-1231. PubMed ID: 29798336
[No Abstract] [Full Text] [Related]
6. Efficacy of induction chemotherapy combined with chrono-chemotherapy and intensity-modulated radiotherapy on locally advanced nasopharyngeal carcinoma.
Zhang S; Liu TTGLYLQLWHY
J BUON; 2021; 26(3):774-780. PubMed ID: 34268935
[TBL] [Abstract][Full Text] [Related]
7. Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.
Wang L; Wu Z; Xie D; Lv S; Xia L; Su Y
Radiat Oncol; 2020 Jul; 15(1):160. PubMed ID: 32615984
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma.
Aftab O; Liao S; Zhang R; Tang N; Luo M; Zhang B; Shahi S; Rai R; Ali J; Jiang W
Radiat Oncol; 2020 Mar; 15(1):66. PubMed ID: 32178698
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
Li PJ; Mo HY; Luo DH; Hu WH; Jin T
Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.
Liu MZ; Fang SG; Huang W; Wang HY; Tian YM; Huang RD; Sun Z; Zhao C; Lu TX; Huang Y; Han F
Cancer Med; 2019 Aug; 8(10):4633-4643. PubMed ID: 31268626
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Endoscopic Nasopharyngectomy Combined With Low-Dose Radiotherapy for Primary T1-2 Nasopharyngeal Carcinoma.
Zhang B; Li Y; Weng J; Huang B; Ban M; Lan G; Lu Y; Luo J; Qu S; Si Y
Technol Cancer Res Treat; 2021; 20():15330338211011975. PubMed ID: 33896244
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study.
Zhang WW; Lin JY; Wang GY; Huang CL; Tang LL; Mao YP; Zhou GQ; Liu LZ; Tian L; Li JB; Ma J; Guo R
Radiother Oncol; 2024 May; 194():110189. PubMed ID: 38432309
[TBL] [Abstract][Full Text] [Related]
14. The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.
Song JH; Wu HG; Keam BS; Hah JH; Ahn YC; Oh D; Noh JM; Park HJ; Lee CG; Keum KC; Cha J; Cho KH; Moon SH; Kim JY; Chung WK; Oh YT; Kim WT; Cho MJ; Kay CS; Kim YS
Cancer Res Treat; 2016 Jul; 48(3):917-27. PubMed ID: 26727716
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal granulomatous mass after radiotherapy for nasopharyngeal carcinoma.
Yang L; Li H; Wang H; Zhang H; Wang S; Fry AN; Han WW; Wang D
Auris Nasus Larynx; 2016 Jun; 43(3):330-5. PubMed ID: 26791589
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of conservative and nasal endoscopic therapy for residual nasopharyngeal carcinoma].
Li D
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 30(24):1950-1953. PubMed ID: 29798272
[No Abstract] [Full Text] [Related]
17. [Clinical efficacy of alternating chemo-radiotherapy for locally advanced nasopharyngeal carcinoma].
You X; Yang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):376-80. PubMed ID: 24961123
[TBL] [Abstract][Full Text] [Related]
18. [A prospective study of surgery combined with concurrent radiochemotherapy in the treatment of patients with early stage nasopharyngeal carcinoma].
Si Y; Tao Z; Zhang Z; Qin Y; Zhou F; Huang B; Lu J; Li B; Lan G; Weng J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 26(9):422-5. PubMed ID: 22803412
[TBL] [Abstract][Full Text] [Related]
19. Locally advanced nasopharyngeal carcinoma in adolescents treated with tomotherapy: Experience at King Faisal Specialist Hospital and Research Centre.
Aldakheel A; Aldehaim M; Alwhaid MS; Alhabib R; Anwar MS; Alzayed B; Shehzad K; Ghebeh H; Al-Rajhi N
Ann Saudi Med; 2024; 44(3):153-160. PubMed ID: 38853474
[TBL] [Abstract][Full Text] [Related]
20. A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma.
Gundog M; Basaran H; Bozkurt O; Eroglu C
Braz J Otorhinolaryngol; 2020; 86(6):676-686. PubMed ID: 31164277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
